Using Esterase Selectivity to Determine the In Vivo Duration of Systemic Availability and Abolish Systemic Side Effects of Topical β-Blockers.
Autor: | Baker, Jillian G., Fromont, Christophe, Bruder, Marjorie, Thompson, Kevin S. J., Kellam, Barrie, Hill, Stephen J., Gardiner, Sheila M., Fischer, Peter M. |
---|---|
Zdroj: | ACS Pharmacology & Translational Science; 8/14/2020, Vol. 3 Issue 4, p737-748, 12p |
Databáze: | Supplemental Index |
Externí odkaz: |